Pharma and Biotech
Period Ending | Period | Revenue (£m) | Pre-tax (£m) | EPS | Dividend |
---|---|---|---|---|---|
30-Sep-23 | Interim | n/a | (0.96) | (0.80)p | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-21 | n/a | (0.35) | (0.24)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-23 | n/a | (4.86) | (4.40)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Forecasts data is not available for this company.
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | n/a | n/a | n/a | 0 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 0.95p |
Closing Price Change | 0.000p |
% Change | 0.00 % |
52 Week High | 12.60 |
52 Week Low | 0.95 |
Volume | 0 |
Shares Issued | 146.91m |
Market Cap | £1.40m |
Value |
---|
Value |
---|
Income |
---|
Growth |
---|
No dividends found |
You are here: research